Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine

Clinical Chemistry

Volumn 60, Issue 8, 2014, Pages 1089-1097

  Woldemariam, Getachew A ^a,b,c   Butch, Anthony W ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; RECOMBINANT CHORIONIC GONADOTROPIN; TRYPSIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOPING; GLYCOSYLATION; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; IMMUNOEXTRACTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MAGNETIC FIELD; MALE; NORMAL HUMAN; TANDEM MASS SPECTROMETRY; URINALYSIS;

CHORIONIC GONADOTROPIN; HUMANS; IMMUNOASSAY; LIMIT OF DETECTION; MALE; TANDEM MASS SPECTROMETRY;

EID: 84905215965     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.222703     Document Type: Article

References (32)

1. Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 2009;7:8.
2. Stenman UH, Tiitinen A, Alfthan H, Valmu L. The classification, functions and clinical use of different isoforms of hCG. Hum Reprod Update 2006;12:769-84. (Pubitemid 44605514)
3. Fontaine YA, Burzawa-Gerard E. Esquisse de l'evolution des hormones gonadotropes et thyreotropes des vertebres. Gen Comp Endocrinol 1977;32:341-7. (Pubitemid 8174055)
4. Stenman UH, Hotakainen K, Alfthan H. Gonadotropins in doping: pharmacological basis and detection of illicit use. Br J Pharmacol 2008;154:569-83. (Pubitemid 351744939)
5. Odell WD, Griffin J. Pulsatile secretion of human chorionic-gonadotropin in normal adults. N Engl J Med 1987;317:1688-91. (Pubitemid 18024408)
6. Hoermann R, Spoettl G, Moncayo R, Mann K. Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary. J Clin Endocrinol Metab 1990;71:179-86.
7. Fishel SB, Edwards RG, Evans CJ. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro. Science 1984;223:816-8. (Pubitemid 14185158)
8. Nisula BC, Blithe DL, Akar A, Lefort G, Wehmann RE. Metabolic fate of human choriogonadotropin. J Steroid Biochem 1989;33:733-7. (Pubitemid 20026149)
9. Cole LA. HCG variants, the growth factors which drive human malignancies. Am J Cancer Res 2014;2:22-35.
10. Wehmann RE, Blithe DL, Flack MR, Nisula BC. Metabolic-clearance rate and urinary clearance of purified beta-core. J Clin Endocrinol Metab 1989;69:510-7. (Pubitemid 19221219)
11. Alfthan H, Haglund C, Dabek J, Stenman UH. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the betasubunit in serum and urine of men and nonpregnant women. Clin Chem 1992;38:1981-7.
12. Grenache DG, Greene DN, Dighe AS, Fantz CR, Hoefner D, McCudden C, Sokoll L, Wiley CL, Gronowski AM. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays. Clin Chem 2010;56:1839-44.
13. Knorr D, Beckmann D, Bidlingmaier F, Helmig FJ, Sippell WG. Plasma testosterone in male puberty. II. hCG stimulation test in boys with hypospadia. Acta Endocrinol 1979;90:365-71. (Pubitemid 9112405)
14. World Anti-Doping Agency. The 2014 prohibited list. http://www.wada-ama. org/Documents/World-Anti-Doping-Program/WADP-Prohibited-list/2014/ WADA-prohibited-list-2014-EN.pdf (Accessed April 2014).
15. World Anti-Doping Agency. Guidelines: reporting & management of human chorionic gonadotrophin (hCG) findings. http://www.wadaama.org/Documents/ Resources/Guidelines/WADA-Guidelines-Reporting-Management-hCG-findings-v1.0-EN. pdf (Accessed April 2014).
16. Cole LA, Sutton JM, Higgins TNM, Cembrowski GS. Between-method variation in human chorionic gonadotropin test results. Clin Chem 2004;50:874-82. (Pubitemid 38543666)
17. Sturgeon CM, Berger P, Bidart JM, Birken S, Burns C, Norman RJ, Stenman UH. Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem 2009;55:1484-91.
18. Cole LA. hCG, five independent molecules. Clin Chim Acta 2012;413:48-65.
19. Liu CL, Bowers LD. Immunoaffinity trapping of urinary human chorionic gonadotropin and its high-performance liquid chromatographic-mass spectrometric confirmation. J Chromatogr B Biomed Appl 1996;687:213-20. (Pubitemid 27008320)
20. Gam LH, Tham SY, Latiff A. Immunoaffinity extraction and tandem mass spectrometric analysis of human chorionic gonadotropin in doping analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2003;792:187-96.
21. Lund H, Lovsletten K, Paus E, Halvorsen TG, Reubsaett L. Immuno-MS based targeted proteomics: highly specific, sensitive, and reproducible human chorionic gonadotropin determination for clinical diagnostics and doping analysis. Anal Chem 2012;84:7926-32.
22. Lund H, Torsetnes SB, Paus E, Nustad K, Reubsaet L, Halvorsen TG. Exploring the complementary selectivity of immunocapture and MS detection for the differentiation between hCG isoforms in clinically relevant samples. J Proteome Res 2009;8:5241-52.
23. Berger P, Paus E, Hemken PM, Sturgeon C, Stewart WW, Skinner JP, et al. Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop. Tumour Biol 2013;34:4033-57.
24. Lund H, Paus E, Berger P, Stenman UH, Torcellini T, Halvorsen TG, Reubsaet L. Epitope analysis and detection of human chorionic gonadotropin (hCG) variants by monoclonal antibodies and mass spectrometry. Tumor Biol 2014;35:1013-22.
25. Kroll MH, Emancipator K. A theoretical evaluation of linearity. Clin Chem 1993;39:405-13. (Pubitemid 23099004)
26. Cole LA, Kardana A, Fu CY, Birken S. The biological and clinical-significance of nicks in human chorionic-gonadotropin and its free beta-subunit. Yale J Biol Med 1991;64:627-37.
27. Lund H, Snilsberg AH, Paus E, Halvorsen TG, Hemmersbach P, Reubsaet L. Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males. Anal Bioanal Chem 2013;405:1569-76.
28. Hoermann R, Berger P, Spoettl G, Gillesberger F, Kardana A, Cole LA, Mann K. Immunological recognition and clinical-significance of nicked human chorionic-gonadotropin in testicular cancer. Clin Chem 1994;40:2306-12.
29. Cole LA. Familial hCG syndrome. J Reprod Immunol 2012;93:52-7.
30. Stenman UH, Unkila-Kallio L, Korhonen J, Alfthan H. Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control. Clin Chem 1997;43:1293-8. (Pubitemid 27297281)
31. Yarram SJ, Jenkins J, Cole LA, Brown NL, Sandy JR, Mansell JP. Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations. Fertil Steril 2004;82:232-3. (Pubitemid 38968808)
32. Bassett R, De Bellis C, Chiacchiarini L, Mendola D, Micangeli E, Minari K, et al. Comparative characterisation of a commercial human chorionic gonadotrophin extracted from human urine with a commercial recombinant human chorionic gonadotrophin. Curr Med Res Opin 2005;21:1969-76. (Pubitemid 41803108)